Bank of Shanghai (SHA:601229) adjusted the conversion price of its 20 billion yuan convertible bonds, according to a Shanghai bourse filing on Tuesday.
The conversion price was adjusted to 8.35 yuan per share from 8.57 yuan per share, effective June 8, after the implementation of the 2025 profit distribution.
Carnaby Resources' (ASX:CNB) recent drill results "materially" strengthen the long-term production profile of the Greater Duchess copper-gold project, according to a Tuesday Euroz Hartleys note.The company said on Tuesday that it intersected 232 meters at 1.3% copper equivalent, including 65 meters at 2.9% copper equivalent, at the Miniboom Lode Discovery of its Greater Duchess Project in Queensland, Australia.The research firm noted that the company is looking to complete its feasibility study for the project mid-year, ahead of a final investment decision, and targeted first ore production in the second half of the year.Euroz Hartleys kept a speculative buy rating on Carnaby Resources while its price target of AU$0.96 is under review.The company's shares rose almost 9% to their highest since May 2024 on market close.
Guangzhou Baiyunshan Pharmaceutical (SHA:600332, HKG:0874) branch entity, Baiyunshan Pharmaceutical General Factory, received drug registration from China's medical products regulator for oseltamivir phosphate for oral suspension.The drug treats influenza A and B, according to a Tuesday filing with the Shanghai bourse.
China Petrochemical Development (TPE:1314) board has appointed Ko Shu-Jen as chairperson, effective Monday, according to a same-day Taiwan Exchange filing.Shares rose 6% in Tuesday's midday trade.Ko replaces Chen Ruey-Long, who previously held the position as chairperson of the company.